MedAssurant appreciates and understands the importance of each project’s return-on-investment and the pressures within the healthcare industry with regard to not only quality but also financial performance. With this in mind, MedAssurant provides its clients with a comprehensive detailing of the financial impact delivered by CARA™ and its associated claims analysis solutions. Down to the penny, MedAssurant’s clients are informed of precise member, practitioner, clinic, disease, and geographical data and trends. MedAssurant does not leave clients guessing or unclear as to the financial expectation of their pre- and post-CARA™ reimbursement picture. With strict adherence to up-to-date variations in CMS, state-based, and commercial risk adjustment specifications MedAssurant greatly assists its clients in their pursuit of accurate bids, improved quality, forecasting, and superior financial performance.